{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:09:37Z","timestamp":1790928577116,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.neuropharm.2005.01.027","type":"journal-article","created":{"date-parts":[[2005,4,4]],"date-time":"2005-04-04T13:28:54Z","timestamp":1112621334000},"page":"73-85","source":"Crossref","is-referenced-by-count":74,"title":["mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition"],"prefix":"10.1016","volume":"49","author":[{"given":"M.","family":"Pietraszek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gravius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Trifanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Danysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2005.01.027_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(03)01935-6","article-title":"In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand","volume":"473","author":"Anderson","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bjp.0703904","article-title":"Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges","volume":"132","author":"Attucci","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib3","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1523\/JNEUROSCI.20-21-07871.2000","article-title":"Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus","volume":"20","author":"Awad","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib4","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1523\/JNEUROSCI.18-20-08394.1998","article-title":"Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine","volume":"18","author":"Bakshi","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0306-4522(98)00752-0","article-title":"Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats","volume":"92","author":"Bakshi","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib6","first-page":"787","article-title":"Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response","volume":"271","author":"Bakshi","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1006\/mcne.2001.0992","article-title":"Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission","volume":"17","author":"Battaglia","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib8","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1523\/JNEUROSCI.22-22-09679.2002","article-title":"Two distinct signaling pathways upregulate NMDA receptor responses via two distinct metabotropic glutamate receptor subtypes","volume":"22","author":"Benquet","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib9","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1111\/j.1460-9568.2003.03073.x","article-title":"Disruption of prepulse inhibition in mice lacking mGluR1","volume":"18","author":"Brody","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF03033300","article-title":"Interactions of the mGluR5 gene with breeding and maternal factors on startle and prepulse inhibition in mice","volume":"6","author":"Brody","year":"2004","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0014-2999(99)00072-2","article-title":"Group I mGlu receptor modulation of dopamine release in the rat striatum in vivo","volume":"369","author":"Bruton","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib12","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.npp.1300540","article-title":"The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety","volume":"29","author":"Busse","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00213-004-1827-5","article-title":"The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats","volume":"175","author":"Campbell","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0960-894X(02)00997-6","article-title":"[3H]-Methoxymethyl-MTEP and [3H]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor","volume":"13","author":"Cosford","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/jm025570j","article-title":"3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity","volume":"46","author":"Cosford","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0091-3057(94)90506-1","article-title":"Glutamate antagonists have different effects on spontaneous locomotor activity in rats","volume":"48","author":"Danysz","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib17","unstructured":"Danysz, W., Pietraszek, M., Gravius, A., Sukhanov, I.M., Bespalov, A.Y, Maciejak, P., Szyndler, J., Plaznik, A., 2004. Activity of mGluR1 and mGluR5 metabotropic glutamate receptor antagonists in animal models of anxiety. Program No. 115.6. Abstract Viewer\/Itinerary Planner. Society for Neuroscience, Washington, DC."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(01)01296-1","article-title":"Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620","volume":"428","author":"De Vry","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.mp.4000848","article-title":"The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia","volume":"6","author":"Devon","year":"2001","journal-title":"Mol. Psychiat."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0028-3908(97)00001-4","article-title":"(RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus","volume":"36","author":"Doherty","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib21","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1176\/appi.ajp.158.9.1400","article-title":"N-Methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia","volume":"158","author":"Dracheva","year":"2001","journal-title":"Am. J. Psychiat."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib22","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1523\/JNEUROSCI.4650-03.2004","article-title":"Decreased phosphorylation of NMDA receptor type 1 at serine 897 in brains of patients with schizophrenia","volume":"24","author":"Emamian","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0028-3908(03)00209-0","article-title":"Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats","volume":"45","author":"Golembiowska","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0028-3908(02)00214-9","article-title":"Corticostriatal LTP requires combined mGluR1 and mGluR5 activation","volume":"44","author":"Gubellini","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib25","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1523\/JNEUROSCI.22-13-05452.2002","article-title":"Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the pyk2\/src-family kinase pathway in cortical neurons","volume":"22","author":"Heidinger","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0028-3908(02)00332-5","article-title":"The mGluR5 antagonist MPEP, but not the mGluR2\/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity","volume":"43","author":"Henry","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01245347","article-title":"Typical and atypical neuroleptics antagonize mk-801-induced locomotion and stereotypy in rats","volume":"89","author":"Hoffman","year":"1992","journal-title":"J. Neural Transm.: Gen. Sect."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF02244950","article-title":"The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801","volume":"111","author":"Hoffman","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib29","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/sj.npp.1300417","article-title":"Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release","volume":"29","author":"Homayoun","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib30","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1126\/science.288.5472.1832","article-title":"mGluR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination, and motor coordination","volume":"288","author":"Ichise","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0006-3223(92)90043-Y","article-title":"NMDA-associated glycine binding site increases in schizophrenic brains","volume":"32","author":"Ishimaru","year":"1992","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0091-3057(94)90554-1","article-title":"Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats","volume":"48","author":"Jackson","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib33","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1176\/ajp.151.8.1234","article-title":"Amelioration of negative symptoms in schizophrenia by glycine","volume":"151","author":"Javitt","year":"1994","journal-title":"Am. J. Psychiat."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1101\/lm.5.4.331","article-title":"Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5","volume":"5","author":"Jia","year":"1998","journal-title":"Learning Memory"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0006-3223(91)90025-H","article-title":"Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle","volume":"30","author":"Keith","year":"1991","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0169-328X(97)00102-2","article-title":"Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocorte,x and hippocampus","volume":"48","author":"Kerner","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/jpet.103.048702","article-title":"Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents","volume":"306","author":"Kinney","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans \u2013 psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiat."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib39","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1523\/JNEUROSCI.21-16-06058.2001","article-title":"Activation of metabotropic glutamate receptor 1 accelerates NMDA receptor trafficking","volume":"21","author":"Lan","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib40","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neuropharm.2003.11.014","article-title":"Metabotropic glutamate 1 receptor distribution and occupancy in the rat brain: a quantitative autoradiographic study using","volume":"46","author":"Lavreysen","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib41","first-page":"295","article-title":"Novel, centrally active mGluR1 antagonists: in vitro and in vivo pharmacology","volume":"43","author":"Lesage","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib42","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1523\/JNEUROSCI.17-13-05196.1997","article-title":"Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP","volume":"17","author":"Lu","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","article-title":"Study of a new schizophrenomimetic drug: Sernyl","volume":"81","author":"Luby","year":"1959","journal-title":"Arch. Neurol. Psychiat."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib44","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1523\/JNEUROSCI.21-16-05925.2001","article-title":"Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function","volume":"21","author":"Mannaioni","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0091-3057(01)00561-5","article-title":"Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone","volume":"69","author":"Mansbach","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0893-133X(89)90035-3","article-title":"Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat","volume":"2","author":"Mansbach","year":"1989","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib47","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1523\/JNEUROSCI.21-18-07001.2001","article-title":"Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata","volume":"21","author":"Marino","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib48","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1097\/00001756-199809140-00012","article-title":"Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats","volume":"9","author":"Martin","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib49","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/0014-2999(95)00333-G","article-title":"Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors","volume":"280","author":"Maurel-Remy","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib50","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0165-0173(99)00044-2","article-title":"Glutamate receptor expression in schizophrenic brain","volume":"31","author":"Meador-Woodruff","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib51","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib52","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0169-328X(98)00063-1","article-title":"Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia","volume":"56","author":"Ohnuma","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib54","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1471-4159.2004.02358.x","article-title":"NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR","volume":"89","author":"Olszewski","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib55","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1358\/dnp.1998.11.9.863689","article-title":"Glutamate in CNS disorders as a target for drug development. An update","volume":"11","author":"Parsons","year":"1998","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib56","unstructured":"Pietraszek, M., Gravius, A., Danysz, W., 2004a. Comparison of the effects of mGluR1 and mGluR5 antagonists in animal models relevant for psychotomimetic activity. Program No. 349.17. Abstract Viewer\/Itinerary Planner. Society for Neuroscience, Washington, DC."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib57","first-page":"587","article-title":"Opposite influence of MPEP, an mGluR5 antagonist, on the locomotor hyperactivity induced by PCP and amphetamine","volume":"55","author":"Pietraszek","year":"2004","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib58","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(01)00297-4","article-title":"Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons","volume":"106","author":"Pisani","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib59","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1523\/JNEUROSCI.23-01-00122.2003","article-title":"Distinct functional roles of the metabotropic glutamate receptors 1 and 5 in the rat globus pallidus","volume":"23","author":"Poisik","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib60","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.neuropharm.2004.02.002","article-title":"Both mGluR1 and mGluR5 mediate Ca2+ release and inward currents in hippocampal CA1 pyramidal neurons","volume":"46","author":"Rae","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008877-199601000-00001","article-title":"Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia","volume":"7","author":"Sams-Dodd","year":"1996","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib62","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0028-3908(99)00092-1","article-title":"Pharmacological agents acting at subtypes of metabotropic glutamate receptors","volume":"38","author":"Schoepp","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neulet.2003.10.028","article-title":"Role of the medial prefrontal cortex in N-methyl-D-aspartate receptor antagonist induced sensorimotor gating deficit in rats","volume":"355","author":"Schwabe","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib64","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1523\/JNEUROSCI.17-19-07503.1997","article-title":"Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus","volume":"17","author":"Shigemoto","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib65","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1471-4159.1992.tb10041.x","article-title":"Excitatory transmitter amino acid release from the ischemic rat cerebral cortex - effects of adenosine receptor agonists and antagonists","volume":"58","author":"Simpson","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib66","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0006-8993(99)02282-9","article-title":"Simultaneous action of MK-801 (Dizclopine) on dopamine, glutamate, aspartate and GABA release from striatum isolated nerve endings","volume":"854","author":"Sitges","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib67","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.fbp.0000081783.35927.8f","article-title":"Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders","volume":"14","author":"Spooren","year":"2003","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib68","doi-asserted-by":"crossref","first-page":"9043","DOI":"10.1523\/JNEUROSCI.21-22-09043.2001","article-title":"Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: a potential role for Homer","volume":"21","author":"Swanson","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1196\/annals.1300.019","article-title":"A role for noradrenergic transmission in the actions of phencyclidine and the antipsychotic and antistress effects of mGlu2\/3 receptor agonists","volume":"1003","author":"Swanson","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib70","first-page":"1290","article-title":"Seroquel restores sensorimotor gating in phencyclidine-treated rats","volume":"279","author":"Swerdlow","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib71","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s002130050741","article-title":"Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine treated rats","volume":"140","author":"Swerdlow","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib72","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0028-3908(99)00223-3","article-title":"Metabotropic glutamate autoreceptors of the mGlu(5) subtype positively modulate neuronal glutamate release in the rat forebrain in vitro","volume":"39","author":"Thomas","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib73","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0006-3223(98)00279-0","article-title":"D-Serine added to antipsychotics for the treatment of schizophrenia","volume":"44","author":"Tsai","year":"1998","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib74","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(00)80810-7","article-title":"Coupling of mGluR\/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins","volume":"23","author":"Tu","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jcp.10081","article-title":"Distinct physiological roles of the Gq-coupled metabotropic glutamate receptors Co-expressed in the same neuronal populations","volume":"191","author":"Valenti","year":"2002","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib76","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0893-133X(98)00072-4","article-title":"M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats","volume":"20","author":"Varty","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.027_bib77","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF00173026","article-title":"Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats","volume":"350","author":"Wedzony","year":"1994","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib78","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0091-3057(93)90217-H","article-title":"The role of dopamine and AMPA\/kainate receptors in the nucleus accumbens in the hypermotility response to MK801","volume":"46","author":"Willins","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2005.01.027_bib79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-2999(97)01435-0","article-title":"Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex","volume":"341","author":"Yonezawa","year":"1998","journal-title":"Eur. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805000699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805000699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T20:53:24Z","timestamp":1683060804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390805000699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0028390805000699"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2005.01.027","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}